DistressOther
IO Biotech, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
IO Biotech, Inc. -> target
On March 31, 2026, after considering all strategic alternatives, IO Biotech, Inc.
Open source record (SEC) ↗